These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21451944)

  • 21. Circulating levels of allopregnanolone, an anticonvulsant metabolite of progesterone, in women with partial epilepsy in the postcritical phase.
    Galli R; Luisi M; Pizzanelli C; Monteleone P; Casarosa E; Iudice A; Murri L
    Epilepsia; 2001 Feb; 42(2):216-9. PubMed ID: 11240592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female.
    Scharfman HE; MacLusky NJ
    Epilepsia; 2006 Sep; 47(9):1423-40. PubMed ID: 16981857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproductive endocrine considerations and hormonal therapy for women with epilepsy.
    Herzog AG
    Epilepsia; 1991; 32 Suppl 6():S27-33. PubMed ID: 1959509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular and molecular effects of steroid hormones on CNS excitability.
    Smith SS; Woolley CS
    Cleve Clin J Med; 2004 Feb; 71 Suppl 2():S4-10. PubMed ID: 15379294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The anticonvulsant effects of progesterone and its metabolites on amygdala-kindled seizures in male rats.
    Lonsdale D; Nylen K; McIntyre Burnham W
    Brain Res; 2006 Jul; 1101(1):110-6. PubMed ID: 16784731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in sex steroid levels in women with epilepsy on treatment: relationship with antiepileptic therapies and seizure frequency.
    Galimberti CA; Magri F; Copello F; Arbasino C; Chytiris S; Casu M; Ameri P; Perucca P; Murialdo G
    Epilepsia; 2009 Jan; 50 Suppl 1():28-32. PubMed ID: 19125844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurosteroid withdrawal model of perimenstrual catamenial epilepsy.
    Reddy DS; Kim HY; Rogawski MA
    Epilepsia; 2001 Mar; 42(3):328-36. PubMed ID: 11442149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of steroid hormones in women with mild catamenial epilepsy.
    Hussain Z; Qureshi MA; Hasan KZ; Aziz H
    J Ayub Med Coll Abbottabad; 2006; 18(3):17-20. PubMed ID: 17348306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen-priming can enhance progesterone's anti-seizure effects in part by increasing hippocampal levels of allopregnanolone.
    Frye CA; Rhodes ME
    Pharmacol Biochem Behav; 2005 Aug; 81(4):907-16. PubMed ID: 16085296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Perspectives of neurosteroid derivative application in antiepileptic therapy].
    Borowicz KK; Czuczwar SJ
    Przegl Lek; 2005; 62(11):1293-5. PubMed ID: 16512623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Catamenial seizures--an analysis].
    Bauer J; Hocke A; Elger CE
    Nervenarzt; 1995 Oct; 66(10):760-9. PubMed ID: 7501092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiepileptic drugs and hormonal contraceptives in adolescent women with epilepsy.
    Zupanc ML
    Neurology; 2006 Mar; 66(6 Suppl 3):S37-45. PubMed ID: 16567741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epilepsy in women: the science of why it is special.
    Morrell MJ
    Neurology; 1999; 53(4 Suppl 1):S42-8. PubMed ID: 10487515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catamenial epilepsy: a review.
    Newmark ME; Penry JK
    Epilepsia; 1980 Jun; 21(3):281-300. PubMed ID: 6991251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurosteroids and their role in sex-specific epilepsies.
    Reddy DS
    Neurobiol Dis; 2014 Dec; 72 Pt B():198-209. PubMed ID: 24960208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unbalanced progesterone and estradiol secretion in catamenial epilepsy.
    Bonuccelli U; Melis GB; Paoletti AM; Fioretti P; Murri L; Muratorio A
    Epilepsy Res; 1989; 3(2):100-6. PubMed ID: 2651113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy.
    Tuveri A; Paoletti AM; Orrù M; Melis GB; Marotto MF; Zedda P; Marrosu F; Sogliano C; Marra C; Biggio G; Concas A
    Epilepsia; 2008 Jul; 49(7):1221-9. PubMed ID: 18325018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel therapeutic approach for treatment of catamenial epilepsy.
    Joshi S; Sun H; Rajasekaran K; Williamson J; Perez-Reyes E; Kapur J
    Neurobiol Dis; 2018 Mar; 111():127-137. PubMed ID: 29274741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inter-ictal and post-ictal circulating levels of allopregnanolone, an anticonvulsant metabolite of progesterone, in epileptic children.
    Grosso S; Luisi S; Mostardini R; Farnetani M; Cobellis L; Morgese G; Balestri P; Petraglia F
    Epilepsy Res; 2003 Apr; 54(1):29-34. PubMed ID: 12742593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormonal effects on epilepsy in women.
    Klein P; Herzog AG
    Epilepsia; 1998; 39 Suppl 8():S9-16. PubMed ID: 9915615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.